3 news items
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients
ATHA
12 Jun 24
be insufficient to support regulatory submissions or approval; Athira may not be able to recruit sufficient patients for its clinical trials
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
ATHA
15 Apr 24
or approval; Athira may not be able to recruit sufficient patients for its clinical trials; the outcome of legal proceedings that have been or may
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease
ATHA
11 Apr 24
not be able to recruit sufficient patients for its clinical trials; the outcome of legal proceedings that have been or may in the future be instituted
- Prev
- 1
- Next